A Real World Observational Study to Evaluate the Impact of Adalimumab Therapy on Quality of Life and Psychological Factors Associated With Severe Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2015
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Acronyms Body Image
- Sponsors Abbott Laboratories; AbbVie
- 02 Jun 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Nov 2013 Planned number of patients changed from 150 to 152 as reported by ClinicalTrials.gov.
- 19 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.